Alibaba Group Holding Limited American Depositary Shares, each represents eight Ordinary Shares
BABADividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 13, 2026 | $1.05 | 2026-06-11 | 2026-06-11 |
| July 10, 2025 | $0.95 | 2025-06-12 | 2025-06-12 |
| July 10, 2025 | $1.05 | 2025-06-12 | 2025-06-12 |
| July 12, 2024 | $0.66 | 2024-06-13 | 2024-06-13 |
| July 12, 2024 | $1.00 | 2024-06-13 | 2024-06-13 |
Dividends Summary
- Consistent Payer: Alibaba Group Holding Limited American Depositary Shares, each represents eight Ordinary Shares has rewarded shareholders with 6 dividend payments over the past 2 years.
- Total Returned Value: Investors who held BABA shares during this period received a total of $5.71 per share in dividend income.
- Latest Payout: The most recent dividend of $1.05/share was paid 5 days ago, on July 13, 2026.
- Yield & Schedule: BABA currently pays dividends yearly with an annual yield of 0.91%.
- Dividend Growth: Since 2024, the dividend payout has grown by 5.0%, from $1.00 to $1.05.
Company News
Rosen Law Firm has launched a securities investigation into Alibaba Group Holding Limited following allegations by Anthropic that Alibaba obtained illicit access to Claude AI through fake accounts. The news triggered a 2.7% decline in Alibaba's American Depositary Shares on June 24, 2026. The firm is preparing a class action lawsuit to recover in...
Apple is predicted to overtake Nvidia as the world's most valuable company, driven by strong iPhone sales growth in China (24% YoY) and the recent approval of Apple Intelligence in the country. Despite higher memory chip costs pressuring competitors, Apple has maintained pricing strategy while gaining market share, particularly as Chinese consume...
Apple stock reached a record high following positive AI developments. The company is testing technology from PrismML that could run advanced AI models directly on iPhones, reducing cloud computing costs. Additionally, China's Cyberspace Administration approved Apple to provide AI services, with Alibaba and Baidu partnering to integrate their AI m...
Pomerantz LLP announced investigations into potential securities fraud at AstraZeneca following the failure of its Phase-3 CARDIO-Transform trial for Wainua treatment, which caused the stock to drop 5.7%. The firm is also investigating claims against Alibaba Group and Franklin Covey Co.
Pomerantz LLP is investigating securities fraud claims against Alibaba Group Holding Limited following two major incidents: Anthropic's accusation of illicit access to Claude AI through fake accounts, which caused a 7.34% stock price drop, and a $600 million non-prosecution agreement with the U.S. Department of Justice for failing to prevent ille...
